Latest CLO news

  • CLO market shrugs off 1% Libor rate

    The three month Libor rate topped 1% for the first time since 2009 this month, raising concerns among CLO and leveraged loan players, though most sources say they are confident that credit fundamentals are strong enough to withstand rate related shocks.

    • 19 Jan 2017
  • Gridlock in CLOs as managers feel loan squeeze

    Tight conditions in the European leveraged loan market are proving a boon for borrowers such as private equity houses, but CLO managers, which form a large proportion of the lending base to that market, are starting to feel the pain. CLO equity investors at the bottom of the chain will determine how far the screws can be turned, write David Bell and Max Bower.

    • 19 Jan 2017
  • US CLO senior spreads rally, but mezz set to widen

    Spreads on new issue CLO senior bonds have rallied with the first deal of the year, but mezzanine spreads look likely to widen after a deluge of lower rated paper flooded the secondary market in the past week.

    • 19 Jan 2017
  • Former 3iDM CLO manager joins Partners Group

    Andrew Bellis, a former managing director at 3i Debt Management, has joined private markets investment firm Partners Group in London.

    • 19 Jan 2017
  • EU CLO investors eye fat mezzanine debt spreads

    European CLO investors are targeting mezzanine and junior tranches of US and European deals, as wide spreads further down the capital stack lag the aggressive tightening seen in senior paper.

    • 17 Jan 2017
  • Secondary CLO volume jumps past 2016 average

    US CLO trading volumes last week topped the average level seen in 2016, as low supply of new issuance drove investors to the secondary market.

    • 17 Jan 2017
  • Euro CLO refi activity chugs on amid primary pause

    Carlyle released price guidance for the refinancing of its Carlyle Global Market Strategies Euro CLO 2014-2 on Monday, as the primary CLO pipeline takes a back seat to a wave of refinancing deals.

    • 16 Jan 2017
  • Pharma back in focus for CLOs after Trump comments

    The pharmaceuticals industry is back under the microscope of US CLO players after comments on drug pricing from president-elect Donald Trump hinted at a tougher environment for drug makers under a Trump presidency.

    • 12 Jan 2017
  • Leveraged loan prices blocking new CLO pipeline

    The US CLO market is off to a slow start and managers are expecting more of the same through the first quarter of the year, as tightening in the leveraged loans market puts pressure on the economics of issuing new deals.

    • 11 Jan 2017
  • UK banks slip out synthetic CLOs before year-end

    Barclays, Lloyds, RBS and Santander UK all priced synthetic CLOs for risk transfer purposes just before the year-end, honing their capital positions for full year 2016 reporting. Most of the deals focused on large corporates, an asset class that fuelled much of last year’s boom in risk transfer trades, as banks seek ways to get ahead of increased Basel risk weights.

    • 05 Jan 2017

CLO news archive

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 16 Jan 2017
1 JPMorgan 19,492.11 46 8.85%
2 UniCredit 18,866.65 83 8.57%
3 HSBC 16,021.11 53 7.27%
4 BNP Paribas 13,314.73 89 6.05%
5 Credit Suisse 13,152.31 32 5.97%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 17 Jan 2017
1 NatWest Markets 216.56 3 8.11%
2 BNP Paribas 201.55 3 7.54%
3 HSBC 199.05 3 7.45%
3 Credit Suisse 199.05 3 7.45%
5 UniCredit 155.26 2 5.81%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 10 Jan 2017
1 JPMorgan 297.36 3 36.61%
2 RBC Capital Markets 85.86 2 10.57%
3 Wells Fargo Securities 85.71 1 10.55%
3 Mizuho 85.71 1 10.55%
3 Goldman Sachs 85.71 1 10.55%